According to the DEP network interaction analysis, epimedin C alleviated T2DM and regulated lipid metabolism partially by increasing the expression levels of Pla2g12b, Cyp4a14, and Apob and decreasing the expression level of Pck1 in the livers of T2DM mice. Here, APOB is linked to type 2 diabetes mellitus.